Mlp Saglik Hizmetleri As Class B · BIST:MPARK

Mlp Saglik Hizmetleri As Class B — MLP Care — FY2023 Earnings Presentation

21 slides from Mlp Saglik Hizmetleri As Class B's earnings presentation, Mar 20, 2024

  1. Slide 1: MLPCARE FY 2023 Presentation

    MLPCARE FY 2023 PRESENTATION M a r c h 2 0 th, 2 0 2 4

  2. Slide 2: Forward Looking Statements

    Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care’s future performance and should be considered as good faith estimates made by the Company. These forward-looking statements reflect management expectations and are based upon currently ava

  3. Slide 3: Muharrem Usta, Chairman & CEO

    MUHARREM USTA CHAIRMAN & CEO

  4. Slide 4: MLP is a Household Name in Turkey

    MLP is a Household Name in Turkey 5.2 million patients1 visited MLP Care hospitals in 2023 Awareness Visits  What are the first private hospital names that come  Which hospitals shown on the screen have you to your mind? ever visited?  When you thik about private hospitals, among the  Which hosp

  5. Slide 5: 2023 Financials at a Glance

    2023 Financials at a Glance Revenue • Strong real growth in revenue (19%), EBITDA (35%) and profit TL 22,449 m before tax (22%) 19% (TAS 29) 85% (w/o TAS 29) • Net profit slightly declined compared to last year due to one-off expenses such as earthquake tax and deferred tax expense related to inflat

  6. Slide 6: # of People Top-up Insurance Users Exceeds 4.1m

    # of People Top-up Insurance Users Exceeds 4.1m # of People with Insurance in Turkey (in thousand) 2,853 4,118 6,971 2,671 3,604 6,275 Growth (2023 – 2022) 6.8% 14.3% 11.1% PMI Top-up PMI+Top-up # of People with Top-up Insurance in Turkey (in thousand) 2023; 4,118 2022; 3,604 Average LTM Addition to

  7. Slide 7: FMT Revenue Increases in USD Terms – w/o TAS impact

    FMT Revenue Increases in USD Terms – w/o TAS 29 impact Medical Tourism Revenue (USD m) TOP 10 FMT Revenue % by Department in FY 2023 114 106 12% 11% 11% 80 6% 6% 5% 4% 3% 3% 3% General Surgery Brain and Neuro Gynecology and Cardiology Hematology Hematology Medical Oncology Check Up Orthopedics Bioch

  8. Slide 8: MLP Care Expands in Foreign Countries

    MLP Care Expands in Foreign Countries Liv Hospital DMC Liv Bona Dea Hospital Location: Budapest / Hungary Location: Baku / Azerbaijan Opening Date: November 2023 Opening Date: July 2022 Key Statistics Key Statistics  22.0k sqm  13.0k sqm  154 Bed Capacity  156 Bed Capacity  7 Operating Theatres

  9. Slide 9: Clear Leader in Private Hospital Provision in Türkiye

    Clear Leader in Private Hospital Provision in Türkiye MLP Care network (# of hospitals and locations)  National and local leader with a İstanbul Samsun network covering the greatest 9 Kocaeli Ordu Trabzon number of cities 2 2 1 2  39% of beds located in the 1 1 1 Tokat attractive Istanbul market Ç

  10. Slide 10: Slide 10

  11. Slide 11: Financial Highlights

    Financial Highlights Revenue (TLm) EBITDA (TLm) Net Income (TLm) %85 %108 %42 %19 %35 %3 22,449 5,784 18,903 4,891 4,748 4,269 2022 2023 2022 2023 2022 2023 Denotes growth / decrease of Revenue, EBITDA, and Net Income vs. the same period of the last year with TAS 29 11 Denotes growth of Revenue, EBI

  12. Slide 12: Prudent Cost Management – TAS 29

    Prudent Cost Management – TAS 29 Cost of Service and G&A Expenses as a % of Revenues Cost Saving Measures enables us to reach the favourable EBITDA Margin EBITDA Margin 1.2%  Material costs as a % of revenue decreased by 411bps 0.8% due to delayed impact of higher costs on expenses thanks to effect

  13. Slide 13: Leverage Ratio Improves – TAS 29

    Leverage Ratio Improves – TAS 29 4,400 Net Debt (TLm) 5.0 3,900 3,400 2,085 2,900 2,261 2,400 1,900 1,400 1,297 900 Reduction 315mTL 982 0.8x 400 0.6x -100 0.0 2022 2023 Net Debt (exc. IFRS 16) IFRS 16 Net Debt/EBITDA 13

  14. Slide 14: Strong Cash Generation – TAS 29

    Strong Cash Generation – TAS 29 Maintenance Capex (TLm) Total Capex (TLm) OCF/ EBITDA FCF/ EBITDA 4.5% 106.8% 73.5% 4.0% 9.5% 98.0% 63.5% 6.1% 5,665 4,290 851 902 1,796 4,560 1,330 2,713 2022 2023 2022 2023 2022 2023 2022 2023 % of Revenue % of Revenue % of EBITDA % of EBITDA 14

  15. Slide 15: All Payer Types Continue to Grow

    All Payer Types Continue to Grow FY 2023*  SSI coverage allows us to reach the 3% majority of Turkish population 14%  Self pay increases via premium service 15% offering and elective procedures  PMI, Top-up & Contracted Institutions market share grows rapidly on the back of strong growth of top-u

  16. Slide 16: Q&A

    Q&A

  17. Slide 17: Closing Remarks

    Closing Remarks MUHARREM USTA CHAIRMAN & CEO

  18. Slide 18: Thank You!

    Thank You! MLP Care Investor Relations Deniz Can Yücel +90 212 227 5555 (Ext: 1148) deniz.yucel@mlpcare.com http://investor.mlpcare.com/en/

  19. Slide 19: Historical Balance Sheet

    Historical Balance Sheet Audited Audited TLm December 31, 2023 December 31, 2022 Cash and cash equivalents 2,812 1,262 Financial investments -- 353 Trade receivables 3,657 3,010 Inventory 1,077 1,174 Short term other assets 913 1,166 Current assets 8,460 6,965 Tangible and intangible fixed assets 8,

  20. Slide 20: Historical P&L Statements

    Historical P&L Statements Audited Audited Change (%) TLm 2023 2022 Revenues 22,449 18,903 %18.8 Cost of service (-) (16,019) (14,016) %14.3 Gross profit 6,430 4,887 %31.6 General administration expenses (-) (2,189) (1,869) %17.1 Other income from operations 953 898 %6.2 Other expenses from operation

  21. Slide 21: EBITDA Reconciliation

    EBITDA Reconciliation TLm 2023 2022 Change(%) Revenue 22,449 18,903 18.8% Cost of service (16,019) (14,016) 14.3% Gross profit 6,430 4,887 31.6% General administrative expenses (-) (2,189) (1,869) 17.1% Depreciation and amortization expenses (Cost of service) 1,405 1,120 25.4% Depreciation and amort

MLP Care — FY2023 Earnings Presentation on 6ix